1WHO/FAO Expert Consultation (2003) Diet, Nutrition and the Prevention of Chronic Diseases. Report of a Joint WHO/FAO Expert Consultation, pp. 1–149. . Geneva: WHO.
5Richtlijnen voor farmaco-economisch onderzoek, College voor zorgverzekeringen, Diemen (2006) . http://www.cvz.nl.
6Cleemput, I, Van Wilder, P, Vrijens, F, et al. (2008) 78C.
8Tan-Torres Edejer, T, Baltussen, R, Adam, T, et al. (2003) Making choices in health. WHO Guide to Cost-Effectiveness Analysis. Geneva: World Health Organization.
9Graf von der Schulenburg, JM, Greiner, W, Jost, F, et al. (2008) Hanover Consensus Group. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus. Value Health 11, 539–544.
10McCarron, DA & Heaney, RP (2004) Estimated healthcare savings associated with adequate dairy food intake. Am J Hypertens 17, 88–97.
11Dall, TM, Fulgoni, VL III, Zhang, Y, et al. (2009) Potential health benefits and medical cost savings from calorie, sodium, and saturated fat reductions in the American diet. Am J Health Promot 23, 412–422.
12Dall, TM, Fulgoni III, VL, Zhang, Y, et al. (2009) Predicted national productivity implications of calorie and sodium reductions in the American diet. Am J Health Promot 23, 23–430.
13Cox, HL, Laupland, KB & Manns, BJ (2006) Economic evaluation in critical care medicine. J Crit Care 21, 117–124.
14Heaney, RP (2008) Nutrients, endpoints, and the problem of proof. J Nutr 138, 1591–1595.
15Heaney, RP & Rafferty, K (2009) Preponderance of the evidence, an example from the issue of calcium intake and body composition. Nutr Rev 67, 32–39.
16Koretz, RL (2005) Nutrition Society Symposium on end points in clinical nutrition trials. Death, morbidity and economics are the only end points for trials. Proc Nutr Soc 64, 277–-284.
17Wahlqvist, ML, Hsu-Hage, BH-H & Lukito, W (1999) Clinical trials in nutrition. Asia Pac J Clin Nutr 8, 231–241.
18Genton, L, van Gemert, W, Pichard, C, et al. (2005) Physiological functions should be considered as true end points of nutritional intervention studies. Proc Nutr Soc 64, 285–296.
19Commission Directive (1999) .
20Paré, P, Gray, J, Lam, S, et al. (2006) Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clin Ther 28, 1726–1735.
21Ravasco, P, Monteiro-Grillo, I, Vidal, PM, et al. (2004) Cancer, disease and nutrition are key determinants of patients' quality of life. Support Care Cancer 12, 246–252.
23Bidlack, WR (1996) Interrelationships of food, nutrition, diet and health: The National Association of State Universities and Land Grant Colleges White Paper. J Am Coll Nutr 15, 422–433.
24Cohen, JT, Neumann, PJ & Weinstein, MC (2008) Does preventive care save money? Health economics and the presidential candidates. N Engl J Med 358, 661–663.
25Kahn, R, Robertson, RM, Smith, R, et al. (2008) The impact of prevention on reducing the burden of cardiovascular disease. Circulation 118, 576–585.
26Kim, JJ & Goldie, SJ (2008) Health and economic implications of HPV vaccination in the United States. N Engl J Med 359, 821–832.
27Gliklich, RE & Dreyer, NA (editors) (2007) Registries Evaluating Patient Outcomes: A User's Guide. Agency for Healthcare Research and Quality.
28AHRQ Conference on Health Care Data Collection and Reporting – Collecting and Reporting Data for Performance Measurement, Moving Toward Alignment (2006) Report of Proceedings. http://healthit.ahrq.gov/portal/server.pt/gateway/PTARGS_O_227079_O_O_18/AHRQ_DataReport_final.pdf.
29Jacobs, P, Bachynsky, J & Baladi, JF (1995) A comparative review of pharmacoeconomic guidelines. Pharmacoeconomics 8, 182–189.
30Weinstein, MC & Fineberg, HV (1980) Clinical Decision Analysis, pp. 228–265. Philadelphia, PA: WB Saunders Co.
31Suarez, FL, Savaiano, D, Arbisi, P, et al. (1997) Tolerance to the daily ingestion of two cups of milk by individuals claiming lactose intolerance. Am J Clin Nutr 65, 1502–1506.
32McBean, LD & Miller, GD (1998) Allaying fears and fallacies about lactose intolerance. J Am Diet Assoc 98, 671–676.
33Savaiano, DA, Boushey, CJ & McCabey, GP (2006) Lactose intolerance symptoms assessed by meta-analysis: a grain of truth that leads to exaggeration. J Nutr 136, 1107–1113.
34Nicklas, TA, Qu, H, Hughes, SO, et al. (2009) Prevalence of self-reported lactose intolerance in a multiethnic sample of adults. Nutr Today 44, 222–227.
35Drummond, M, Brixner, D, Gold, M, et al. (2009) (Consensus Development Group) Toward a consensus on the QALY. Value Health 12, S31–S35.
36Rutten-van Mölken, M, Van Busschbach, J and Rutten, F (editors) (2000) From costs to effects: a manual for evaluation studies in health care [in Dutch]. Elsevier Gezondheidszorg.
37Peter, A, Taylor, R, Butler, J, et al. (2003) Returns on Investment in Public Health, an Epidemiological and Economic Analysis. Australian Government. Department of Health and Ageing.
38Claes, C, Reinert, RR & von der Schulenburg, JM (2009) Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects. Eur J Health Econ 10, 25–38.
39Gravelle, H & Smith, D (2000) Discounting for Health Effects in Cost Benefit and Cost Effectiveness Analysis, pp. 20. Centre for Health Economics Technical Paper Series 20.
40Viscusi, WK (1995) Discounting Health Effects for Medical Decisions. Valuing Health Care, pp. 125–147. [Sloan, FA, editor]. Cambridge: Cambridge University Press.
41Sloan, FA (1995) Valuing Health Care. Costs, Benefits and Effectiveness of Pharmaceuticals and Other Medical Technologies. Cambridge: Cambridge University Press.
42Robinson, R (1993) Economic evaluation and health care. What does it mean? Br Med J 307, 670–673.
43Adams, ME, McCall, NT, Gray, DT, et al. (1992) Economic analysis in randomised controlled trials. Med Care 30, 231–243.
44Drummond, MF & Davies, L (1991) Economic analysis alongside clinical trials. Revisiting the methodological issues. Int J Technol Assess Health Care 7, 561–573.
45Drummond, MF, Ludbrook, A, Lowson, K, et al. (1986) Studies in Economic Appraisal in Health Care, Oxford: Oxford University Press.
47Arriola, L, Martinez-Camblor, P, Larrañaga, N, et al. (2010) Alcohol intake and the risk of coronary heart disease in the Spanish EPIC cohort study. Heart 96, 124–130.